🌟 Bilix: Korea’s Biotech Innovator Turns PEG‑Bilirubin into Next‑Gen Therapies
Introduction Imagine harnessing a natural antioxidant—one that your body already produces—and transforming it into a powerful treatment for inflammation, oxidative stress, and even cancer. That’s exactly what Bilix, a Seoul-based biotech startup, is doing with its proprietary PEGylated bilirubin platform called Brixelle®. This groundbreaking concept is gaining international attention for its potential to deliver first-in-class … 더 읽기